GlassScriptPhysician profile
Summer Cone Hanson
NPI 1487311023
$1,440.80
in general payments reported to CMS, 2019-2025
15 companies · $829 in 2025
The $829 reported for 2025 was more than what 82% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $205 · 2023: $117 · 2024: $290 · 2025: $829.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,236.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,235.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $269.24 | 2024-2025 | Tremfya, Stelara |
| Ardelyx, INC. | $256.14 | 2025 | Ibsrela |
| Astrazeneca Pharmaceuticals LP | $182.80 | 2022-2025 | Farxiga, Fasenra, Airsupra |
| Abiomed | $166.07 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $140.11 | 2024-2025 | Xifaxan |
| Dexcom, INC. | $89.53 | 2025 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $87.20 | 2025 | Zepbound, Mounjaro |
| Novo Nordisk INC | $73.69 | 2025 | Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.44 | 2025 | Jardiance |
| Mylan Specialty L.P. | $34.29 | 2022-2023 | Yupelri |
| Inogen, INC. | $29.74 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Exact Sciences Corporation | $19.61 | 2025 | The Cologuard Plus Collection Kit |
| Actelion Pharmaceuticals US, INC. | $19.36 | 2023 | Opsumit |
| Abbvie INC. | $15.00 | 2024 | |
| Amgen INC. | $13.58 | 2025 | Evenity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Summer Hanson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.